News As Blenrep returns, GSK adds another ADC to cancer pipeline GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.
News Bayer's prostate cancer drug Nubeqa cleared for NHS use Thousands of men living with incurable prostate cancer will be able to access an easier-to-tolerate treatment from Bayer, thanks to new NICE guidance.
Oncology Current and future standard of care in prostate cancer Despite recent advancements in the field of prostate cancer treatment, there remain distinct gaps in the current standard of care needing improvement.
Oncology The role of advanced imaging in transforming early detection... The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.
News Artera gets FDA okay for prostate cancer AI A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.
News UK MHRA authorises orforglipron private prescription Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
